Paclitaxel Interactions
There are 524 drugs known to interact with paclitaxel, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 60 are major, 446 are moderate, and 18 are minor.
- View all 524 medications that may interact with paclitaxel
- View paclitaxel alcohol/food interactions (1)
- View paclitaxel disease interactions (6)
Most frequently checked interactions
View interaction reports for paclitaxel and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Advil (ibuprofen)
- Aloxi (palonosetron)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Avastin (bevacizumab)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Cytoxan (cyclophosphamide)
- Eliquis (apixaban)
- Emend (aprepitant)
- Fentanyl Transdermal System (fentanyl)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Herceptin (trastuzumab)
- Imodium (loperamide)
- Keytruda (pembrolizumab)
- MiraLAX (polyethylene glycol 3350)
- Neulasta (pegfilgrastim)
- Paracetamol (acetaminophen)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Paclitaxel alcohol/food interactions
There is 1 alcohol/food interaction with paclitaxel.
Paclitaxel disease interactions
There are 6 disease interactions with paclitaxel which include:
- infections
- conduction disorders
- hepatic dysfunction
- myelosuppression
- peripheral neuropathy
- anaphylaxis
Report options
More about paclitaxel
- paclitaxel consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Loqtorzi
Loqtorzi (toripalimab-tpzi) is a PD-1 inhibitor medicine used for the treatment of advanced ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.